Beacon Capital Management LLC (Tennessee)’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-28
Closed -$2.34K – 635
2025
Q2
$2.34K Hold
28
– – ﹤0.01% 880
2025
Q1
$2.36K Hold
28
– – ﹤0.01% 908
2024
Q4
$2.58K Hold
28
– – ﹤0.01% 845
2024
Q3
$2.6K Hold
28
– – ﹤0.01% 935
2024
Q2
$2.31K Hold
28
– – ﹤0.01% 839
2024
Q1
$1.86K Buy
+28
New +$1.73K ﹤0.01% 887

Other funds holding LMAT

Beacon Capital Management LLC (Tennessee)'s LMAT Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 28 shares — an estimated $2.34K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in LMAT in Q1 2024 and held it in 6 quarters. The position peaked at $2.6K in Q3 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 28 LeMaitre Vascular shares in Q3 2025, an estimated $2.34K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in LeMaitre Vascular in Q1 2024 and held it in 6 quarters.
  • Beacon Capital Management LLC (Tennessee)'s LeMaitre Vascular position peaked at $2.6K in Q3 2024.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.